Dermatology research studies the structural proteins that keep skin firm — chiefly collagen and elastin — along with pigmentation, hair follicle activity and how skin repairs itself. Copper-binding peptides are a recurring subject because copper is a cofactor for several enzymes involved in building collagen.
Much of the published work here is topical rather than injected, and cosmetic studies are often small, industry-funded and short. Entries note the study type where it is known.
7 entries in this research area
- AHK-Cu (Copper Tripeptide-3)Copper-binding tripeptide studied in hair follicle and skin research.Laboratory study
- GHK-CuIn catalogueNaturally occurring copper-binding tripeptide, the most studied peptide in skin and collagen research.Laboratory study
- Glow Protocol (GLOW)Vendor blend of three peptides sold for skin research. The blend itself has not been trialled.Controlled clinical trial
- KLOW Protocol (KLOW)Vendor blend of four peptides. Individual components have literature; the blend does not.Controlled clinical trial
- Melanotan I (MT-I)In catalogueMelanocortin receptor agonist approved as an implant for a rare light-sensitivity disorder.
- Melanotan II (MT-II)In catalogueUnlicensed melanocortin agonist studied for pigmentation and sexual response; subject of UK regulator warnings.Early human study
- SNAP-8 (Acetyl Octapeptide-3)Topical cosmetic peptide studied for its effect on expression lines.Controlled clinical trial